Akebia Therapeutics
AKBA
#9606
Rank
โ‚น9.91 B
Marketcap
โ‚น35.72
Share price
-8.71%
Change (1 day)
-74.67%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): -โ‚น14.94

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น14.83. In 2025 the company made an earnings per share (EPS) of -โ‚น1.85 an increase over its 2024 EPS that were of -โ‚น30.58.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น14.94706.01%
2025-โ‚น1.85-93.94%
2024-โ‚น30.58-16.83%
2023-โ‚น36.76-23.7%
2022-โ‚น48.18-69.41%
2021-โ‚น157.52-38.63%
2020-โ‚น256.6717.37%
2019-โ‚น218.682.79%
2018-โ‚น212.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น618.95-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น486.47-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น1,610-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น620.82 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA